Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early enoxaparin after embryo transfer in IVF/ART
IRCT20220530055028N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of enoxaparin in infertility (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Chemical pregnancy and Clinical pregnancy. Started Mar 2023; status: completed.
02
Drugs
enoxaparin
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20220530055028N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220530055028N1.